10 reports

To support the partnership, the Abbott Fund is providing US$## million funds over three years.

  • Chemotherapy
  • HIV AIDS
  • Molecular Diagnostics
  • World
  • Market Size

The drug candidate acts by blocking the histamine receptors and prevents the excess mucus production associated with ocular allergy.

  • Chemotherapy
  • Ear Disease
  • Molecular Diagnostics
  • Therapy
  • Sensorion S.A.

Global In- Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022) ##.

  • Chemotherapy
  • HIV AIDS
  • Molecular Diagnostics
  • World
  • Market Size

Global In- Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022) ##.

  • Chemotherapy
  • HIV AIDS
  • Molecular Diagnostics
  • World
  • Market Size

In addition to these it also provides other drug that reduce the side effects of the drugs.

  • HIV AIDS
  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size

Food and Drug Administration (FDA).

  • Chemotherapy
  • HIV AIDS
  • Molecular Diagnostics
  • North America
  • United States
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Helsinn Group
  • DEXAMETHASONE - DRUG PROFILE
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Helsinn Group

DRUG/ MOLECULE REFERS TO PRIMARY INTERVENTION ONLY. ##.

  • Allergy Drug
  • Clinical Trial
  • Molecular Diagnostics
  • Pharmaceutical
  • World

RESULTS WERE PUBLISHED IN THE INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY.

  • Chemotherapy
  • HIV AIDS
  • Molecular Diagnostics
  • Opioid
  • Opiant Pharmaceuticals, Inc.